You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

camostat mesylate

Showing 51 - 75 of 514
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Soft Tissue Sarcoma Trial in Guangzhou (Apatinib Mesylate, doxorubicin, ifosfamide)

Recruiting
  • Soft Tissue Sarcoma
  • Apatinib Mesylate, doxorubicin, ifosfamide
  • Guangzhou, China
    Sun Yat-sen University Cancer Center
Nov 15, 2021

COVID, Sars-CoV2 Trial in Lexington (Ivermectin, Camostat Mesilate, Artemesia annua)

Terminated
Has Results
  • COVID
  • Sars-CoV2
  • Lexington, Kentucky
    University of Kentucky Markey Cancer Center
Jan 18, 2022

Mydriasis, Dilation Trial in United States (Phentolamine Mesylate Ophthalmic Solution 1%, Phentolamine Mesylate Ophthalmic

Completed
Has Results
  • Mydriasis
  • Dilation
  • Phentolamine Mesylate Ophthalmic Solution 1%
  • Phentolamine Mesylate Ophthalmic Solution Vehicle (Placebo)
  • Pittsburg, Kansas
  • +3 more
Aug 11, 2022

Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia Trial in Worldwide (procedure,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +3 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +21 more
  • Birmingham, Alabama
  • +219 more
Sep 15, 2022

Covid19 Trial in Berlin (Niclosamide + Camostat, Placebo)

Terminated
  • Covid19
  • Niclosamide + Camostat
  • Placebo
  • Berlin, Germany
    Charité Research Organisation GmbH
Nov 26, 2021

Healthy Subjects Trial in Beijing (Apatinib Mesylate)

Completed
  • Healthy Subjects
  • Apatinib Mesylate
  • Beijing, Beijing, China
    Beijing Luhe Hospital, Capital Medical University
Oct 19, 2021

Eosinophilic Myeloid Tumor, Hypereosinophilic Syndrome Trial run by the National Institute of Allergy and Infectious Diseases

Recruiting
  • Eosinophilic Myeloid Neoplasm
  • Hypereosinophilic Syndrome
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Breast Tumor Trial in United States (Eribulin Mesylate, Pembrolizumab)

Completed
Has Results
  • Breast Neoplasm
  • Duarte, California
  • +21 more
Apr 6, 2022

Relapsed/Refractory Rhabdomyosarcoma, Non-rhabdomyosarcoma Soft Tissue Sarcoma, Ewing Sarcoma Trial in United States (Eribulin

Completed
Has Results
  • Relapsed/Refractory Rhabdomyosarcoma
  • +2 more
  • Eribulin mesylate
  • Birmingham, Alabama
  • +40 more
Mar 18, 2022

Neuroblastoma Trial (Apatinib, Irinotecan, Temozolomide)

Not yet recruiting
  • Neuroblastoma
  • Apatinib, Irinotecan, Temozolomide
  • (no location specified)
Aug 29, 2021

Covid19, Diabetes, Hypertension Trial in Mexico City (Camostat Mesilate, Artemisia Annua Leaf)

Terminated
  • Covid19
  • +3 more
  • Camostat Mesilate
  • Artemisia Annua Leaf
  • Mexico City, None - Non-US/Canada, Mexico
    Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubi
Jun 15, 2021

Hepatocellular Carcinoma Trial in Hangzhou (Apatinib Mesylate, Camrelizumab)

Recruiting
  • Hepatocellular Carcinoma
  • Hangzhou, Zhejiang, China
    the First Affiliated Hospital, School of Medicine, Zhejiang Univ
Jan 16, 2022

Gastrointestinal Stromal Tumors Trial in Changsha (Apatinib Mesylate, Sunitinib, Imatinib dosage, Dasatinib, Reveratinib)

Recruiting
  • Gastrointestinal Stromal Tumors
  • Apatinib Mesylate
  • Sunitinib, Imatinib dosage, Dasatinib, Reveratinib
  • Changsha, Hunan, China
    Xiangya Hospital, Central South University
Mar 1, 2023

NAFLD, Nonalcoholic Fatty Liver, NASH - Nonalcoholic Steatohepatitis Trial (LUM-201)

Recruiting
  • NAFLD
  • +2 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Sep 26, 2022

Respiratory Viral Infection, Antiviral Treatment, COVID-19 Trial in Los Angeles (Mitoquinone/mitoquinol mesylate)

Recruiting
  • Respiratory Viral Infection
  • +2 more
  • Mitoquinone/mitoquinol mesylate
  • Los Angeles, California
    University of California Los Angeles
Aug 3, 2022

Corona Virus Infection Trial in Denmark, Sweden (Camostat Mesilate, Placebo oral tablet)

Recruiting
  • Corona Virus Infection
  • Camostat Mesilate
  • Placebo oral tablet
  • Hjørring, Region Nord, Denmark
  • +10 more
Apr 27, 2021

Ergot Alkaloids in Treatment of Salivation in Parkinson's

Enrolling by invitation
  • Main Heading (Descriptor) Terms
  • Dihydroergot mesylate
  • Nanjing, Jiangsu, China
    Dihydroergot mesylate
Sep 6, 2023

Philadelphia Chromosome Positive CML Trial in Worldwide (imatinib mesylate)

Completed
Has Results
  • Philadelphia Chromosome Positive CML
  • imatinib mesylate
  • Chicago, Illinois
  • +9 more
Jun 3, 2021

Locally Advanced or Metastatic and Unresectable HCC Trial in Worldwide (SHR-1210, Apatinib, Sorafenib)

Active, not recruiting
  • Locally Advanced or Metastatic and Unresectable HCC
  • Beverly Hills, California
  • +120 more
Dec 29, 2021

Soft Tissue Injuries Trial (OraVerse)

Not yet recruiting
  • Soft Tissue Injuries
  • (no location specified)
Sep 29, 2022

Dialysis; Complications, Bleeding Trial in Wonju (Nafamostat Mesylate)

Recruiting
  • Dialysis; Complications
  • Bleeding
  • Nafamostat Mesylate
  • Wonju, Kangwondo, Korea, Republic of
    Yonsei Unviersity Wonju College of Medicin
May 22, 2023

Chronic Myelomonocytic Leukemia, Chronic Myeloid Leukemia, Polycythemia Vera Trial in Houston (Imatinib Mesylate (Gleevec))

Completed
Has Results
  • Chronic Myelomonocytic Leukemia
  • +4 more
  • Imatinib Mesylate (Gleevec)
  • Houston, Texas
    UT MD Anderson Cancer Center
Dec 7, 2021

Progression-free Survival, Gastrointestinal Stromal Tumor, Neoadjuvant Trial in Hangzhou (Imatinib)

Recruiting
  • Progression-free Survival
  • +2 more
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, College of Medicine, Zhejiang Uni
Oct 9, 2021

Gastrointestinal Stromal Tumor (GIST) Trial in New York (drug, other, procedure)

Active, not recruiting
  • Gastrointestinal Stromal Tumor (GIST)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Dec 28, 2022

HIV Trial in United States (Delavirdine mesylate, Zidovudine, Didanosine)

Completed
  • HIV Infections
  • Delavirdine mesylate
  • +2 more
  • Stanford, California
  • +9 more
Oct 27, 2021